Inovio Pharmaceuticals, Inc. (INO)

Inovio Pharmaceuticals Revenue

Inovio Pharmaceuticals had revenue of $100.76K in the quarter ending June 30, 2024, a decrease of -55.41%. This brings the company's revenue in the last twelve months to $591.86K, down -93.85% year-over-year. In the year 2023, Inovio Pharmaceuticals had annual revenue of $832.01K, down -91.89%.

• Revenue (ttm): $591.86K
• Revenue Growth: -93.85%
• P/S Ratio: 224.16
• Revenue / Employee: $4,851
• Employees: 122
• Market Cap: 144.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	832.01K	-9.43M	-91.89%
Dec 31, 2022	10.26M	8.49M	478.23%
Dec 31, 2021	1.77M	-5.64M	-76.05%
Dec 31, 2020	7.41M	3.30M	80.24%
Dec 31, 2019	4.11M	-26.37M	-86.51%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.